US Venture Capital Off To Good Start After Record 2015; Tarveda Raises $38m

US biotechnology companies raised a record-breaking $7.4bn in venture capital in 2015, and based on VC fundraising so far in January – including a $38m Series C round for Tarveda Therapeutics Inc. – 2016 looks like it may keep pace with last year.